When PD-L1 expressed on cancer cells interacts with PD-1, a tyrosine-kinase receptor protein expressed by B and T lymphocytes, lymphocyte proliferation is inhibited, leading to cancer survival [6,7,8]. Here, CD274 is linked to cancer.